In vitro and in vivo anti-allergic effects of Arctium lappa L

Experimental Biology and Medicine

Volumn 233, Issue 11, 2008, Pages 1469-1477

  Knipping, Karen ^a   Van Esch, Elisabeth C A M ^a   Wijering, Selva C ^a   Van Der Heide, Sicco ^b   Dubois, Anthony E ^b   Garssen, Johan ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Anti allergic; Arctium lappa; Degranulation; Leukotriene

Indexed keywords

ANTIALLERGIC AGENT; ARCTIIN; ARCTIUM LAPPA EXTRACT; BETA N ACETYLHEXOSAMINIDASE; LEUKOTRIENE; PLANT EXTRACT; UNCLASSIFIED DRUG; ANTIINFLAMMATORY AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; AQUEOUS SOLUTION; ARCTIUM LAPPA; ARTICLE; BASOPHIL; BASOPHIL DEGRANULATION; CELL ACTIVITY; CELL VIABILITY; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; ENZYME RELEASE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; IN VIVO STUDY; LEUKEMIA CELL; MEDIATOR RELEASE; MEDICINAL PLANT; MILK; MILK ALLERGY; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PROSTAGLANDIN SYNTHESIS INHIBITION; RAT; SWELLING; WHEY; ANIMAL; ARCTIUM; BASOPHIL DEGRANULATION TEST; BIOSYNTHESIS; CHEMICALLY INDUCED DISORDER; CHEMISTRY; EAR DISEASE; EDEMA; FRACTIONATION; ISOLATION AND PURIFICATION; METABOLISM; MONONUCLEAR CELL;

ARCTIUM LAPPA; ASTERACEAE; MUS; RATTUS;

ANIMALS; ANTI-ALLERGIC AGENTS; ANTI-INFLAMMATORY AGENTS; ARCTIUM; BASOPHIL DEGRANULATION TEST; BASOPHILS; CHEMICAL FRACTIONATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; EAR DISEASES; EDEMA; HUMANS; LEUKOCYTES, MONONUCLEAR; LEUKOTRIENES; MICE; PLANT EXTRACTS; RATS;

EID: 58249083662     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.3181/0803-RM-97     Document Type: Article

References (48)

1. Ring J, Kramer U, Schafer T, Behrendt H. Why are allergies increasing? Curr Opin Immunol 13:701-708, 2001.
2. Milgrom H. Attainments in atop: special aspects of allergy and IgE. Adv Pediatr 49:273-297, 2002.
3. Pearlman DS. Pathophysiology of the inflammatory response. J Allergy Clin Immunol 104:S132-S137, 1999.
4. Blank U, Rivera J. The ins and outs of IgE-dependent mast-cell exocytosis. Trends Immunol 25:266-273, 2004.
5. Hindmarch I, Shamsi Z. Antihistamines: models to assess sedative properties, assessment of sedation, safety and other side-effects. Clin Exp Allergy 29(Suppl 3):133-142, 1999.
6. Warner JO. The role of leukotriene receptor antagonists in the treatment of chronic asthma in childhood. Allergy 56(Suppl 66):22-29, 2001.
7. Tohda Y, Fujimura M, Taniguchi H, Takagi K, Igarashi T, Yasuhara H, Takahashi K, Nakajima S. Leukotriene receptor antagonist, montelukast, can reduce the need for inhaled steroid while maintaining the clinical stability of asthmatic patients. Clin Exp Allergy 32:1180-1186, 2002.
8. Parnes SM. Targeting cysteinyl leukotrienes in patients with rhinitis, sinusitis and paranasal polyps. Am J Respir Med 1:403-408, 2002.
9. Crowther SD, Rees PJ. Current treatment of asthma-focus on leukotrienes. Exp Opin Pharmacother 1:1021-1040, 2000.
10. Shin HY, Kim JS, An NH, Park RK, Kim HM. Effect of disodium cromoglycate on mast cell-mediated immediate-type allergic reactions. Life Sci 74:2877-2887, 2004.
11. Ratner PH, Ehrlich PM, Fineman SM, Meltzer EO, Skoner DP. Use of intranasal cromolyn sodium for allergic rhinitis. Mayo Clin Proc 77: 350-354, 2002.
12. Allen DB, Bielory L, Derendorf H, Dluhy R, Colice GL, Szefler SJ. Inhaled corticosteroids: past lessons and future issues. J Allergy Clin Immunol 112:S1-S40, 2003.
13. Ten Eick AP, Blumer JL, Reed MD. Safety of antihistamines in children. Drug Saf 24:119-147, 2001.
14. Newnham DM. Asthma medications and their potential adverse effects in the elderly: recommendations for prescribing. Drug Saf 24:1065-1080, 2001.
15. Marguet C, Couderc L, Lubrano M. Adverse events of inhaled steroids in childhood. Arch Pediatr 11(Suppl 2):113s-119s, 2004.
16. Holetz FB, Pessini GL, Sanches NR, Cortez DA, Nakamura CV, Filho BP. Screening of some plants used in the Brazilian folk medicine for the treatment of infectious diseases. Mem Inst Oswaldo Cruz 97:1027-1031, 2002.
17. Lin CC, Lu JM, Yang JJ, Chuang SC, Ujiie T. Anti-inflammatory and radical scavenge effects of Arctium lappa. Am J Chin Med 24:127-137, 1996.
18. Iwakami S, Wu JB, Ebizuka Y, Sankawa U. Platelet activating factor (PAF) antagonists contained in medicinal plants: lignans and sesquiterpenes. Chem Pharm Bull (Tokyo) 40:1196-1198, 1992.
19. Suzuki S, Umezawa T, Shimada M. Stereochemical diversity in lignan biosynthesis of Arctium lappa L. Biosci Biotechnol Biochem 66:1262-1269, 2002.
20. Wang HY, Yang JS. [Studies on the chemical constituents of Arctium lappa L.]. Yao Xue Xue Bao 28:911-917, 1993.
21. Xie LH, Ahn EM, Akao T, Abdel-Hafez AA, Nakamura N, Hattori M. Transformation of arctiin to estrogenic and antiestrogenic substances by human intestinal bacteria. Chem Pharm Bull (Tokyo) 51:378-384, 2003.
22. Yu BS, Yan XP, Xiong J, Xin Q. Simultaneous determination of chlorogenic acid, forsythin and arctiin in Chinese traditional medicines preparation by reversed phase-HPLC. Chem Pharm Bull (Tokyo) 51: 421-424, 2003.
23. Wang X, Li F, Sun Q, Yuan J, Jiang T, Zheng C. Application of preparative high-speed counter-current chromatography for separation and purification of arctiin from Fructus arctii. J Chromatogr A 1063: 247-251, 2005.
24. Sun WJ, Sha ZF, Gao H. [Determination of arctiin and arctigenin in Fructus arctii by reverse-phase HPLC]. Yao Xue Xue Bao 27:549-551, 1992.
25. Mkrtchian TA, Snapian GG, Nikogosian GA. [Pectin production from burdock (Arctium sp.)]. Ukr Biokhim Zh 70:98-105, 1998.
26. Flickinger EA, Hatch TF, Wofford RC, Grieshop CM, Murray SM, Fahey GC, Jr. In vitro fermentation properties of selected fructooligo- saccharide-containing vegetables and in vivo colonic microbial populations are affected by the diets of healthy human infants. J Nutr 132:2188-2194, 2002.
27. Majchrowicz MA. Essiac. Notes Undergr 29 Winter:6-7, 1995.
28. Kardosová A, Ebringerová A, Alföldi J, Nosal'ova G, Franová S, Hríbalová V. A biologically active fructan from the roots of Arctium lappa L., var. Herkules. Int J Biol Macromol 33:135-140, 2003.
29. Takagi K, Nakamura R, Teshima R, Sawada J. Application of human Fc epsilon RI alpha-chain-transfected RBL-2H3 cells for estimation of active serum IgE. Biol Pharm Bull 26:252-255, 2003.
30. Cheong H, Ryu SY, Oak MH, Cheon SH, Yoo GS, Kim KM. Studies of structure activity relationship of flavonoids for the anti-allergic actions. Arch Pharm Res 21:478-180, 1998.
31. Wu X, Biswal SS, Kehrer JP. Roles of 5-lipoxygenase activating protein in cell proliferation and apoptosis. Cell Biol Toxicol 19:135-143, 2003.
32. Hoffmann A, Vieths S, Haustein D. Biologic allergen assay for in vivo test allergens with an in vitro model of the murine type I reaction. J Allergy Clin Immunol 99:227-232, 1997.
33. Linko-Lopponen S, Makinen M. A microtiter plate assay for N-acetyl-beta-D-glucosaminidase using a fluorogenic substrate. Anal Biochem 148:50-53, 1985.
34. Medrala W, Wolanczyk-Medrala A, Malolepszy J, Patkowski J, Litwa M, Gietkiewicz K, Wrzyszcz M. Comparative study between skin prick tests and TOP-CAST allergen leukocyte stimulation in diagnosis of allergic status. J Invest Allergol Clin Immunol 7:115-118, 1997.
35. Erdmann SM, Ventocilla S, Moll-Slodowy S, Sauer I, Merk HF. [Basophil activation tests in the diagnosis of drug reactions]. Hautarzt 56:38-43, 2005.
36. Schmid I, Uittenbogaart CH, Keld B, Giorgi JV. A rapid method for measuring apoptosis and dual-color immunofluorescence by single laser flow cytometry. J Immunol Methods 170:145-157, 1994.
37. Schouten B, van Esch ECAM, Hofman GA, van den Elsen LWJ, Willemsen LEM, Garssen J. Acute allergic skin reactions and intestinal contractility changes in mice orally sensitized against casein or whey. Int Arch Allergy Immunol 147: 125-134, 2008.
38. Vlieg-Boerstra BJ, van der Heide S, Bijleveld CM, Kukler J, Duiverman EJ, Wolt-Plompen SA, Dubois AE. Dietary assessment in children adhering to a food allergen avoidance diet for allergy prevention. Eur J Clin Nutr 60:1384-1390, 2006.
39. Vlieg-Boerstra BJ, van der Heide S, Bijleveld CM, Kukler J, Duiverman EJ, Dubois AE. Placebo reactions in double-blind, placebo-controlled food challenges in children. Allergy 62:905-912, 2007.
40. 40.v Saito H, Hatake K, Dvorak AM, Leiferman KM, Donnenberg AD, Arai N, Ishizaka K, Ishizaka T. Selective differentiation and proliferation of hematopoietic cells induced by recombinant human interleukins. Proc Natl Acad Sci USA 85:2288-2292, 1988.
41. Mayer P, Valent P, Schmidt G, Liehl E, Bettelheim P. The in vivo effects of recombinant human interleukin-3: demonstration of basophil differentiation factor, histamine-producing activity, and priming of GM-CSF-responsive progenitors in nonhuman primates. Blood 74: 613-621, 1989.
42. Lantz CS, Boesiger J, Song CH, Mach N, Kobayashi T, Mulligan RC, Nawa Y, Dranoff G, Galli SJ. Role for interleukin-3 in mast-cell and basophil development and in immunity to parasites. Nature 392:90-93, 1998.
43. Taylor JA, Karas JL, Ram MK, Green OM, Seidel-Dugan C. Activation of the high-affinity immunoglobulin E receptor Fc epsilon RI in RBL- 2H3 cells is inhibited by Syk SH2 domains. Mol Cell Biol 15:4149-4157, 1995.
44. Kraft S, Fleming T, Billingsley JM, Lin SY, Jouvin MH, Storz P, Kinet JP. Anti-CD63 antibodies suppress IgE-dependent allergic reactions in vitro and in vivo. J Exp Med 201:385-396, 2005.
45. Rivera VM, Brugge JS. Clustering of Syk is sufficient to induce tyrosine phosphorylation and release of allergic mediators from rat basophilic leukemia cells. Mol Cell Biol 15:1582-1590, 1995.
46. Sasaki Y, Kimura Y, Tsunoda T, Tagami H. Anaphylaxis due to burdock. Int J Dermatol 42:472-473, 2003.
47. Rodriguez P, Blanco J, Juste S, Garces M, Perez R, Alonso L, Marcos M. Allergic contact dermatitis due to burdock (Arctium lappa). Contact Dermatitis 33:134-135, 1995.
48. Hirono I, Mori H, Kato K, Ushimaru Y, Kato T, Haga M. Safety examination of some edible plants, part 2. J Environ Pathol Toxicol 1: 71-74, 1978.